There seems to be 2 different timelines stated for ethics submission, in Q3 (as stated in the toxicology announcement) and h2cy2024 (as per company slides from May 2024 onwards) This seems a bit ambiguous to me and probably why there has been some talk or 'perception' of a delay. I cant find any where stated that the q3 timeline had changed?
Are you able to elaborate? Thank you
General Comments / Chat, page-11588
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.010(0.56%) |
Mkt cap ! $304.2M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.80 | $1.78 | $106.4K | 59.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.83 | 10000 | 2 |
View Market Depth
| Last trade - 15.57pm 30/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |